# EDWARDS LIFESCIENCES CORPORATION (EW) FY2024 Annual P&L / Income Statement

- Company: EDWARDS LIFESCIENCES CORPORATION (EW)
- Period: 2024-01-01 to 2024-12-31
- Filing: FY2024 10-K, filed 2025-02-28, accession number 0001099800-25-000005
- Page: https://plicit.ai/financials/ew/fy2024-annual-income-statement
- Chart image: https://plicit.ai/charts/ew-fy2024-annual-income-statement-sankey.png

## Chart details: Revenue by Product and Service

Income statement for 2024-01-01 through 2024-12-31. View: Product and service. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Net sales**: 5,439,500,000 US dollars
- **Cost of sales**: 1,117,500,000 US dollars
- **Gross profit**: 4,322,000,000 US dollars
- **Operating costs, net of other operating income (calculated)**: 2,943,300,000 US dollars
- **Operating income**: 1,378,700,000 US dollars
- **Other income (expense), net (calculated)**: 169,400,000 US dollars
- **Income from continuing operations before provision for income taxes**: 1,548,100,000 US dollars
- **Provision for income taxes (Note 19)**: 152,100,000 US dollars
- **Net income**: 4,169,700,000 US dollars
- **Transcatheter Aortic Valve Replacement**: 4,106,100,000 US dollars
- **Transcatheter Mitral and Tricuspid Therapies**: 352,100,000 US dollars
- **Surgical Structural Heart**: 981,300,000 US dollars
- **Selling, general, and administrative expenses**: 1,789,200,000 US dollars
- **Research and development expenses**: 1,053,000,000 US dollars
- **Intellectual property agreement and certain litigation expenses (Note 3)**: 40,400,000 US dollars
- **Change in fair value of contingent consideration liabilities (Note 13)**: 0 US dollars
- **Restructuring charges, separation costs, and other (Note 4)**: 61,000,000 US dollars
- **Other operating income, net**: negative 300,000 US dollars
- **Income from discontinued operations, net of tax**: 2,773,700,000 US dollars. Reported below-tax contribution to net income.

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit, plus the explicitly reported below-tax contributions, equals net income.
- Of which attributable to EDWARDS LIFESCIENCES CORPORATION: $4.17 B; to noncontrolling interests: −$4.90 M.

## Chart details: Revenue by Business Segment

- Page: https://plicit.ai/financials/ew/fy2024-annual-income-statement/revenue-by-business-segment
- Chart image: https://plicit.ai/charts/ew-fy2024-annual-revenue-by-business-segment-sankey.png

Income statement for 2024-01-01 through 2024-12-31. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Net sales**: 5,439,500,000 US dollars
- **Cost of sales**: 1,117,500,000 US dollars
- **Gross profit**: 4,322,000,000 US dollars
- **Operating costs, net of other operating income (calculated)**: 2,943,300,000 US dollars
- **Operating income**: 1,378,700,000 US dollars
- **Other income (expense), net (calculated)**: 169,400,000 US dollars
- **Income from continuing operations before provision for income taxes**: 1,548,100,000 US dollars
- **Provision for income taxes (Note 19)**: 152,100,000 US dollars
- **Net income**: 4,169,700,000 US dollars
- **United States**: 3,206,000,000 US dollars
- **Europe**: 1,321,700,000 US dollars
- **Japan**: 339,800,000 US dollars
- **Rest of World**: 572,000,000 US dollars
- **Selling, general, and administrative expenses**: 1,789,200,000 US dollars
- **Research and development expenses**: 1,053,000,000 US dollars
- **Intellectual property agreement and certain litigation expenses (Note 3)**: 40,400,000 US dollars
- **Change in fair value of contingent consideration liabilities (Note 13)**: 0 US dollars
- **Restructuring charges, separation costs, and other (Note 4)**: 61,000,000 US dollars
- **Other operating income, net**: negative 300,000 US dollars
- **Income from discontinued operations, net of tax**: 2,773,700,000 US dollars. Reported below-tax contribution to net income.

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit, plus the explicitly reported below-tax contributions, equals net income.
- Of which attributable to EDWARDS LIFESCIENCES CORPORATION: $4.17 B; to noncontrolling interests: −$4.90 M.